Literature DB >> 24969756

Treatment of coronary in-stent restenosis with bioabsorbable vascular scaffolds.

Fernando Alfonso1, Julio Nuccio1, Cecilia Cuevas1, Alberto Cárdenas1, Nieves Gonzalo1, Pilar Jimenez-Quevedo1.   

Abstract

Mesh：

Year:  2014        PMID： 24969756     DOI： 10.1016/j.jacc.2013.05.107

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  5 in total

Review 1.  A review of bioresorbable scaffolds: hype or hope?

Authors:  Huay Cheem Tan; Rajiv Ananthakrishna
Journal:  Singapore Med J       Date:  2016-11-21       Impact factor: 1.858

2.  Inhibition of neddylation by MLN4924 improves neointimal hyperplasia and promotes apoptosis of vascular smooth muscle cells through p53 and p62.

Authors:  Tang-Jun Ai; Jian-Yong Sun; Lin-Juan Du; Chaoji Shi; Chao Li; Xue-Nan Sun; Yan Liu; Lihui Li; Zhixiong Xia; Lijun Jia; Jianmiao Liu; Sheng-Zhong Duan
Journal:  Cell Death Differ       Date:  2017-10-13       Impact factor: 15.828

3.  In-Stent Restenosis: Pathophysiology and Treatment.

Authors:  Patrick M Looser; Luke K Kim; Dmitriy N Feldman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-02

4.  Effect of diabetes mellitus on long-term outcomes after repeat drug-eluting stent implantation for in-stent restenosis.

Authors:  Lin Zhao; Weiwei Zhu; Xiaojiang Zhang; Dongfang He; Chengjun Guo
Journal:  BMC Cardiovasc Disord       Date:  2017-01-06       Impact factor: 2.298

Review 5.  Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients.

Authors:  Daniele Giacoppo; Giuseppe Gargiulo; Patrizia Aruta; Piera Capranzano; Corrado Tamburino; Davide Capodanno
Journal:  BMJ       Date:  2015-11-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.